Live Breaking News & Updates on Patients With Breast Cancer

Stay updated with breaking news from Patients with breast cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Disturbed skin microbiome increases the risk of radiodermatitis in radiotherapy patients, finds study

Disturbed skin microbiome increases the risk of radiodermatitis in radiotherapy patients, finds study
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Avidan Neumann , Claudia Traidl Hoffmann , University Hospital , Technical University Of Munich , University Of Augsburg , Association Of Skin Microbiome Dynamics With Radiodermatitis , Technical University , Helmholtz Munich , Environmental Medicine , Skin Microbiome Dynamics With Radiodermatitis , Patients With Breast Cancer ,

Abdou Spotlights Factors Influencing ADC Treatment Selection in Breast Cancer

Dr Abdou discusses how characteristics of patients with breast cancer impact ADC treatment selection and highlights some of the topline takeaways from breast cancer treatment to come out of the 2023 ASCO Annual Meeting. ....

Ryan Scott , Yara Abdou , Department Of Medicine , University Of North Carolina School Medicine , Division Of Oncology , Live On Air , North Carolina School , Onclive On Air , Apple Podcasts , Google Podcasts , Amazon Music , The University Of North Carolina School Medicine , Patients With Breast Cancer , Adc Treatment Selection ,

How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer

HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer. ....

Metastatic Breast Cancer Treatment , Therapies Fight , Positive Metastatic Breast , Educated Patient Sound Bites , Breast Cancer , Sarah Tolaney Md , Patients With Breast Cancer , Breast Cancer Patients , Breast Cancer Treatments , Breast Cancer Therapies , Breast Cancer Management , Breast Cancer Care , Breast Cancer Her2 , Her2 Breast Cancer , Her2 Low Breast Cancer ,

Factors Informing Individualized Treatment Decision-Making for HER2-Positive Metastatic Breast Cancer

Sara M. Tolaney, MD, MPH explains that treatment decisions for metastatic breast cancer are based on the current biopsy showing receptor status, but prior biopsies over the full course of disease are considered as well, particularly for HER2 targeted therapies which may work even if HER2 low expression occurred years earlier. ....

Metastatic Breast Cancer Treatment , Positive Metastatic Breast , Educated Patient Sound Bites , Breast Cancer , Sarah Tolaney Md , Patients With Breast Cancer , Breast Cancer Patients , Breast Cancer Treatments , Breast Cancer Therapies , Breast Cancer Management , Breast Cancer Care , Breast Cancer Her2 , Her2 Breast Cancer , Her2 Low Breast Cancer ,

Guideline-Recommended Treatments for HER2-Negative Metastatic Breast Cancer

Treatment for HER2-negative metastatic breast cancer depends on factors like hormone receptor status, with chemo/immunotherapy for PD-L1-positive triple negative disease, PARP inhibitors for BRCA mutations, and antibody-drug conjugates as options after first line therapy. ....

Educated Patient Sound Bites , Breast Cancer , Sarah Tolaney Md , Patients With Breast Cancer , Breast Cancer Patients , Breast Cancer Treatments , Breast Cancer Therapies , Breast Cancer Management , Breast Cancer Care , Breast Cancer Her2 , Her2 Breast Cancer , Her2 Low Breast Cancer ,